Matthew A. Naylor

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.

Peter D. Davis, Graeme J. Dougherty, David C. Blakey et al. · Oxford University Research Archive (ORA) (University of Oxford) · 2002 · 231 citations

Endothelial Cell Morphology, Chemoprevention Strategy, Tumor Biology +17

Pyrolysis of Polytetrafluoroethylene

Ernest E. Lewis, Matthew A. Naylor · Journal of the American Chemical Society · 1947 · 168 citations

Materials Science, Altmetrics, Engineering +15

Synthesis and evaluation of .alpha.-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of .alpha.-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins

Terence C. Jenkins, Matthew A. Naylor, Peter O’Neill et al. · Journal of Medicinal Chemistry · 1990 · 82 citations

Indolequinone Antitumor Agents:  Reductive Activation and Elimination from (5-Methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl Derivatives and Hypoxia-Selective Cytotoxicity in Vitro

Matthew A. Naylor, Elizabeth Swann, Steven A. Everett et al. · Journal of Medicinal Chemistry · 1998 · 69 citations

Bioreductive Activation of a Series of Indolequinones by Human DT-Diaphorase:  Structure−Activity Relationships

Roger M. Phillips, Matthew A. Naylor, Mohammed Jaffar et al. · Journal of Medicinal Chemistry · 1999 · 60 citations

Bioorganic Chemistry, Engineering, Aldo-keto Reductase +20